Among these inhibitory receptors, cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and programmed cell death protein 1 (PD-1) have been well characterized in T cells and have been shown to play an important role in regulating T cell activation and effector functions, particularly in the context of cancer immunology [1]. The gene discussed is CTLA4; the disease is cancer.